Pharmanex
This article was originally published in The Tan Sheet
Executive Summary
Q2 sales total $95.3 mil., down 1% on reported basis, but up 10% in local currency terms. Sales boosted by relaunch in Japan of company's LifePak supplements, reformulated to capsules from tablets. In addition, 30% of firm's sales during period were generated by automatic monthly reorders, an increasingly important transaction to the business, Pharmanex notes. Outside U.S., sales for Cholestin rose 10% from first quarter. Reformulated version of the supplement, excluding red yeast rice, launched stateside in July (1"The Tan Sheet" July 16, In Brief)
You may also be interested in...
Cholestin
New formulation contains Policor (policosanol), "beeswax-based" proprietary ingredient that inhibits cholesterol synthesis in liver, Pharmanex says July 9. NuSkin Enterprises division removed original red yeast rice-containing Cholestin from market following Utah federal court decision favoring FDA determination the product was a drug because it contained lovastatin, the active ingredient in Merck's Mevacor (1"The Tan Sheet" May 7, p. 15). Once-daily formula developed by Hauser replaces twice-daily red yeast rice dosage and is made with novel PoliSorb softgel delivery system. Thirty-count bottles marked "new and improved" are priced at $39.95
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands